Stocks Health care XAIR
NASDAQ · Health careBeyond Air, Inc. (XAIR)
Beyond Air, Inc. brought in $7.7M of revenue over the twelve months to June 30, 2026, up 60.7% from a year earlier. It posted a net loss of $33.5M. In fiscal 2026 capital spending exceeded operating cash flow by $19.2M. At June 30, 2026 it held $5.5M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
What Beyond Air, Inc. does
Beyond Air, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker XAIR.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2026 | $7.7M | -$33.2M | -$4.01 | -$19.2M |
| 2025 | $3.7M | -$46.6M | -$13.77 | -$44.1M |
| 2024 | $1.2M | -$60.2M | -$36.32 | -$61.8M |
| 2023 | n/a | -$55.8M | -$37.12 | -$36.9M |
| 2022 | n/a | -$43.2M | -$33.53 | -$24.5M |
| 2021 | $873K | -$22.9M | -$25.34 | -$20.5M |
Full financial statements: income, balance sheet and cash flow
Where XAIR ranks in Health care
Latest SEC filings
What Beyond Air, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 24, 2026
- August 24, 2026
- August 18, 2026
- August 17, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026Quarterly report 10-Q · period to June 30, 2026Revenue was flat at $1.8M versus the same quarter last year; diluted EPS -$11.00 versus -$30.67.
- August 6, 2026Other event 8-K
- July 31, 2026
- July 16, 2026Passive stake changed SCHEDULE 13G/A
- July 14, 2026Passive stake (5% or more) SCHEDULE 13G
Insider trades
What the people running Beyond Air, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders bought $225K worth of shares on the open market in the last 90 days and sold none.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| July 29, 2026 | Moorhead Daniel JChief Financial Officer | Bought | 4,340 | $25K |
| July 29, 2026 | Goodman Robert ScottChief Executive Officer, Director | Bought | 34,722 | $200K |
Who owns XAIR
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Lin Yi-Chien13G, passive | 8.3% | July 14, 2026 |
| Balyasny Asset Management L.P.13G, passive with 4 related filers | 5.3% | August 14, 2026 |
Largest institutional holders
Insiders
2 insiders reported holding 39,162 shares in total.
| Holder | Shares |
|---|---|
| Goodman Robert ScottChief Executive Officer, Director | 34,822 |
| Moorhead Daniel JChief Financial Officer | 4,340 |
Questions about XAIR
What does Beyond Air, Inc. do?
Beyond Air, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker XAIR.
Is Beyond Air, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $33.5M on revenue of $7.7M.
How much revenue does Beyond Air, Inc. make?
Over the twelve months to June 30, 2026 Beyond Air, Inc. reported revenue of $7.7M. That is 60.7% more than a year earlier.
When did Beyond Air, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the executive or director change from September 24, 2026.
Similar companies
Compare XAIR with
Follow XAIR
Get an email when Beyond Air, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow XAIR: get an email when it filesWhere the numbers come from
Financial figures are the values Beyond Air, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.